These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 9863388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Histopathologic characteristics of bone marrow in patients with aplastic anemia].
    Milosević R, Janković G, Antonijević N, Jovanović V, Babić D, Colović M.
    Srp Arh Celok Lek; 2000; 128(5-6):200-4. PubMed ID: 11089422
    [Abstract] [Full Text] [Related]

  • 3. [Survival in amyotrophic lateral sclerosis].
    Alcaz S, Jarebinski M, Pekmezović T, Marinković Z, Apostolski S.
    Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.
    Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meusers P, Salama A, Heimpel H.
    N Engl J Med; 1991 May 09; 324(19):1297-304. PubMed ID: 2017225
    [Abstract] [Full Text] [Related]

  • 6. Acquired severe aplastic anaemia in adults--a single centre study with 13 years follow-up.
    de Planque MM, Richel DJ, Fibbe WE, den Ottolander GJ, Guiot HF, Zwaan FE.
    Neth J Med; 1990 Oct 09; 37(3-4):103-10. PubMed ID: 2250751
    [Abstract] [Full Text] [Related]

  • 7. Treatment of severe aplastic anemia with high-dose methylprednisolone and antilymphocyte globulin.
    Marmont AM, Bacigalupo A, Van Lint MT, Frassoni F, Podesta M, Reali G, Piaggio G.
    Prog Clin Biol Res; 1984 Oct 09; 148():271-87. PubMed ID: 6379665
    [Abstract] [Full Text] [Related]

  • 8. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK, Kim DW, Lee JW, Han CW, Min WS, Kim CC.
    Haematologica; 2001 Mar 09; 86(3):303-10. PubMed ID: 11255278
    [Abstract] [Full Text] [Related]

  • 9. Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation Group.
    Bacigalupo A.
    Eur J Haematol Suppl; 1996 Mar 09; 60():16-9. PubMed ID: 8987236
    [Abstract] [Full Text] [Related]

  • 10. Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia.
    Viollier R, Passweg J, Gregor M, Favre G, Kühne T, Nissen C, Gratwohl A, Tichelli A.
    Ann Hematol; 2005 Jan 09; 84(1):47-55. PubMed ID: 15340760
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ, Park CY, Park YH, Kim YJ, Kim DW, Min WS, Kim CC.
    Bone Marrow Transplant; 2003 Jan 09; 31(2):79-86. PubMed ID: 12621487
    [Abstract] [Full Text] [Related]

  • 14. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M, van Weel-Sipman MH, Zwinderman AH, Hoogerbrugge PM, Vossen JM, Egeler RM.
    Ned Tijdschr Geneeskd; 2002 Aug 17; 146(33):1542-6. PubMed ID: 12212502
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia.
    Werner EJ, Stout RD, Valdez LP, Harris RE.
    Pediatrics; 1989 Jan 17; 83(1):61-5. PubMed ID: 2642621
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Jan 17; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 17. Severe acquired aplastic anemia in children: 11-year experience with bone marrow transplantation and immunosuppressive therapy.
    Halpérin DS, Grisaru D, Freedman MH, Saunders EF.
    Am J Pediatr Hematol Oncol; 1989 Jan 17; 11(3):304-9. PubMed ID: 2675660
    [Abstract] [Full Text] [Related]

  • 18. CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
    Arranz R, Conde E, Rodriguez-Salvanés F, Pajuelo FJ, Cabrera R, Sanz MA, Petit J, Bueno J, Maldonado J, Odriozola J, Conde JG, Brunet S, Carreras E, Iriondo A, Fernández-Rañada JM, Marín P, Subcomité de Aplasia Medular del Grupo Español de Trasplante Hemopoyético.
    Bone Marrow Transplant; 2002 Feb 17; 29(3):205-11. PubMed ID: 11859392
    [Abstract] [Full Text] [Related]

  • 19. Aplastic anaemia in Christchurch Hospital 1979-89.
    Baker BW, Smith MP, Abbott GD, Beard ME, Spearing RL, Heaton DC.
    N Z Med J; 1991 Nov 13; 104(923):468-70. PubMed ID: 1945172
    [Abstract] [Full Text] [Related]

  • 20. [Hematopoietic stem-cell transplantation in aplastic anemia].
    Hernández-Rivera EG.
    Rev Invest Clin; 2005 Nov 13; 57(2):298-304. PubMed ID: 16524071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.